Women, kidney disease, and pregnancy

Andrew Smyth, Milan Radovic, Vesna D Garovic

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Several glomerular diseases may occur in women of childbearing age. Pregnancy in such patients should be planned when the disease has been in remission for a minimum of 6 months to minimize maternal and fetal complications. Immunosuppressive agents should be optimized before conception to include those that are safe for pregnancy. The complexity of medical management when caring for these patients calls for a multidisciplinary team approach consisting of a nephrologist, rheumatologist, obstetrician, and pharmacist. This review will address the physiological changes of pregnancy that may affect glomerular disease presentation, activity, and diagnosis; specific glomerular diseases primary and secondary to systemic diseases in the context of pregnancy; fetal and maternal complications and long-term effects; diagnosis and differential diagnosis; and treatment strategies that are considered relatively safe with respect to fetal intrauterine exposure.

Original languageEnglish (US)
Pages (from-to)402-410
Number of pages9
JournalAdvances in Chronic Kidney Disease
Volume20
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Kidney Diseases
Pregnancy
Mothers
Immunosuppressive Agents
Pharmacists
Differential Diagnosis

Keywords

  • Glomerular disease
  • Kidney disease
  • Preeclampsia
  • Pregnancy
  • Proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this

Women, kidney disease, and pregnancy. / Smyth, Andrew; Radovic, Milan; Garovic, Vesna D.

In: Advances in Chronic Kidney Disease, Vol. 20, No. 5, 09.2013, p. 402-410.

Research output: Contribution to journalArticle

Smyth, Andrew ; Radovic, Milan ; Garovic, Vesna D. / Women, kidney disease, and pregnancy. In: Advances in Chronic Kidney Disease. 2013 ; Vol. 20, No. 5. pp. 402-410.
@article{207c8dc04bbd40bcb8fe9546efcc8165,
title = "Women, kidney disease, and pregnancy",
abstract = "Several glomerular diseases may occur in women of childbearing age. Pregnancy in such patients should be planned when the disease has been in remission for a minimum of 6 months to minimize maternal and fetal complications. Immunosuppressive agents should be optimized before conception to include those that are safe for pregnancy. The complexity of medical management when caring for these patients calls for a multidisciplinary team approach consisting of a nephrologist, rheumatologist, obstetrician, and pharmacist. This review will address the physiological changes of pregnancy that may affect glomerular disease presentation, activity, and diagnosis; specific glomerular diseases primary and secondary to systemic diseases in the context of pregnancy; fetal and maternal complications and long-term effects; diagnosis and differential diagnosis; and treatment strategies that are considered relatively safe with respect to fetal intrauterine exposure.",
keywords = "Glomerular disease, Kidney disease, Preeclampsia, Pregnancy, Proteinuria",
author = "Andrew Smyth and Milan Radovic and Garovic, {Vesna D}",
year = "2013",
month = "9",
doi = "10.1053/j.ackd.2013.06.004",
language = "English (US)",
volume = "20",
pages = "402--410",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Women, kidney disease, and pregnancy

AU - Smyth, Andrew

AU - Radovic, Milan

AU - Garovic, Vesna D

PY - 2013/9

Y1 - 2013/9

N2 - Several glomerular diseases may occur in women of childbearing age. Pregnancy in such patients should be planned when the disease has been in remission for a minimum of 6 months to minimize maternal and fetal complications. Immunosuppressive agents should be optimized before conception to include those that are safe for pregnancy. The complexity of medical management when caring for these patients calls for a multidisciplinary team approach consisting of a nephrologist, rheumatologist, obstetrician, and pharmacist. This review will address the physiological changes of pregnancy that may affect glomerular disease presentation, activity, and diagnosis; specific glomerular diseases primary and secondary to systemic diseases in the context of pregnancy; fetal and maternal complications and long-term effects; diagnosis and differential diagnosis; and treatment strategies that are considered relatively safe with respect to fetal intrauterine exposure.

AB - Several glomerular diseases may occur in women of childbearing age. Pregnancy in such patients should be planned when the disease has been in remission for a minimum of 6 months to minimize maternal and fetal complications. Immunosuppressive agents should be optimized before conception to include those that are safe for pregnancy. The complexity of medical management when caring for these patients calls for a multidisciplinary team approach consisting of a nephrologist, rheumatologist, obstetrician, and pharmacist. This review will address the physiological changes of pregnancy that may affect glomerular disease presentation, activity, and diagnosis; specific glomerular diseases primary and secondary to systemic diseases in the context of pregnancy; fetal and maternal complications and long-term effects; diagnosis and differential diagnosis; and treatment strategies that are considered relatively safe with respect to fetal intrauterine exposure.

KW - Glomerular disease

KW - Kidney disease

KW - Preeclampsia

KW - Pregnancy

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=84882758111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882758111&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2013.06.004

DO - 10.1053/j.ackd.2013.06.004

M3 - Article

C2 - 23978545

AN - SCOPUS:84882758111

VL - 20

SP - 402

EP - 410

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 5

ER -